We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Prospective cohort study shows CA125 levels indicate adverse outcomes in Sjögren’s syndrome patients, suggesting a potential biomarker.
Clinical trials.govs: NCT04370158, Registration date: 30 April 2020.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: